KirstenLGruisMD

Neurology • Syracuse, NY

Neuromuscular Medicine, Neurophysiology

Associate Professor, Neurology, University of Michigan Medical School

Join to view full profile

Dr. Gruis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gruis' full profile

Already have an account?

Office
90 Presidential Plz
4th Floor - Neurology
Syracuse, NY 13202
Phone+1 315-464-4243

Fax+1 315-464-5350

Education & Training

University of MichiganFellowship, Clinical Neurophysiology, 2002 - 2003
University of MichiganResidency, Neurology, 1999 - 2002
Johns Hopkins UniversityInternship, Internal Medicine, 1998 - 1999
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1998

Certifications & Licensure

MI State Medical License 2002 - 2027
NY State Medical License Active through 2013
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2007 Apr 01
Completed
Phase 1
Study of Standard Noninvasive Positive Pressure Ventilation (NIPPV) and Low Expiratory Pressure NIPPV in ALS Patients Start of enrollment: 2008 Jan 01
Completed
Not Applicable

Publications & Presentations

PubMed

55 citations
Barriers to and mediators of brain-computer interface user acceptance: focus group findings.
Stefanie Blain-Moraes, Riley Schaff, Kirsten L. Gruis, Jane E. Huggins, Patricia A. Wren
Ergonomics. 2012-04-26
114 citations
What would brain-computer interface users want? Opinions and priorities of potential users with amyotrophic lateral sclerosis
Jane E. Huggins, Patricia A. Wren, Kirsten L. Gruis
Amyotrophic Lateral Sclerosis. 2011-10-10
137 citations
Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model
Zhigang Yu, Nahid Dadgar, Megan A. Albertelli, Kirsten L. Gruis, Cynthia L. Jordan
The Journal of Clinical Investigation. 2006-10-02

Press Mentions

U.S. Food and Drug Administration (FDA) Grants Prolong Pharmaceuticals FDA Fast Track Designation for Novel Stroke Therapy (PP-007) in HEMERA-1 Clinical StudyOctober 30th, 2024
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2022 Earnings Call TranscriptMarch 31st, 2023
DiaMedica Therapeutics Announces Clinical Hold of Its Phase 2/3 ReMEDy2 Clinical Trial for DM199July 7th, 2022
Join now to see all

Grant Support

Pilot Placebo-Controlled Trial Of Early Noninvasive Ventilation For ALSNational Institute Of Neurological Disorders And Stroke2007–2011